4//SEC Filing
Rosenberg Noah L. 4
Accession 0001209191-21-032319
CIK 0001438533other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:11 PM ET
Size
6.7 KB
Accession
0001209191-21-032319
Insider Transaction Report
Form 4
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-05-11$19.14/sh−375$7,178→ 45,969 total - Sale
Common Stock
2021-05-12$19.46/sh−375$7,298→ 45,594 total
Footnotes (1)
- [F1]The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001579649
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:11 PM ET
- Size
- 6.7 KB